Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Pioneering research technician apprenticeship programme wins major award
A pioneering apprenticeship programme at the ICR for aspiring laboratory research technicians has won the Education and Training Award at the UK Pharma Industry Awards.
Large-scale study confirms well-established cancer risk factors and identifies new ones
Researchers have examined thousands of genetically defined traits to identify possible causal relationships for eight common cancers.
New biological findings open the door to improved outcomes for young adults with sarcoma
A new study has answered the long-standing question of why improvements in survival outcomes for young people with cancerous soft tissue tumours have lagged behind those for their paediatric and older adult counterparts.
ICR among best UK universities for commercialisation, partnerships and engaging with the public
Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in the Knowledge Exchange Framework (KEF).
Breast and ovarian cancer linked to thousands of new gene variants
New research identifies specific genetic changes that can increase someone's risk of breast and ovarian cancers, to help guide clinical decision-making
ESMO 2024: More than half of advanced melanoma patients treated with combination immunotherapy survive the disease for at least 10 years
More than half of people diagnosed with advanced melanoma are now surviving the disease for ten years or more when they receive a combination immunotherapy treatment, according to a study led by researchers from the ICR and The Royal Marsden.
New drug target discovered for aggressive form of prostate cancer
Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease – it could be a new target for treatment and used to help predict who will become resistant to hormone therapy.
ESMO 2024: Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition
A study has found that people with Li-Fraumeni syndrome would benefit from yearly whole-body MRI scans to screen for cancers.
Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point
Scientists are developing breast cancer risk tools that will help to identify women at high risk, even if they do not have a family history of the disease, thanks to one of the world’s largest and longest-running studies into the causes of breast cancer.
Potential new drug to target rare childhood brain tumour
Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma (DHG), new research has found.
New method could lower radiotherapy doses for some cancer patients
A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients.
ICR welcomes protein degradation expert to lead centre aimed at discovering new ways to treat cancer
Dr Zoran Rankovic has been appointed to direct the pioneering Centre for Protein Degradation at The Institute of Cancer Research (ICR).